2025 ASKP3 Annual Conference
Upholding Integrity in Treatment: Navigating Responsibility, Standards, and Scrutiny in a Critical Era
January 23 – 25, 2025
Austin Marriott Downtown
Austin, TX, USA
Join us for the 2025 ASKP3 Annual Conference engage in dynamic conversations and networking with colleagues and learn about the latest research and resources in ketamine and emerging treatments. This year’s Annual Conference will be hosted at the Austin Marriott Downtown in Austin, Texas, USA, and includes over 19 hours of plenary sessions and concurrent sessions as well as a robust exhibit hall offering up-to-date technology and resources for our industry. Register today and make plans to join us as, together, we explore this year’s Conference theme, Upholding Integrity in Treatment: Navigating Responsibility, Standards, and Scrutiny in a Critical Era.
Conference highlights include:
- Welcome Reception With Exhibitors
- Peer-Reviewed Abstract Presentations From Industry Experts
- Earn up to 19 CMEs and CEs (pending approval)
Registration and Registration Rates:
Registration Types:
A brief description of our registration selection options are as follows:
- Prescriber: physicians, psychotherapists, and practitioners, and includes those with the designation(s) of MD, DO, DNP, APRN, CRNA, and PAs.
- Associate: practitioners with the designation(s) of RN, EdD, LFMT, LPC, LMHC, PhD, PMH-BC, PHM-APRN.
- Resident: 51% or more of time spent being a student or resident in a medical, doctoral, or nursing program.
- Additional Staff: staff working directly under a primary Prescriber who is already registered to attend the Annual Conference.
Target Audience
This program is designed for all clinicians and multidisciplinary practitioners in the ketamine and emerging treatments industry. The American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3) is a non-profit group of professionals dedicated to the safe clinical use of ketamine for mental health disorders and pain conditions.
Attendee Cancellation Policy
Full payment is due at the time of registration. A refund less a $100 processing fee will be given for cancellations that submit a written request to ASKP3. Requests must be received by December 20, 2024. No refunds will be given after December 20, 2024. Requests must be submitted to info@askp.org. In the event that the program is canceled or postponed, we will not be responsible for any travel costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.
Preliminary Attendee Schedule* (*subject to change; CME/CEs pending approval)
11:30 AM – 6:30 PM
Registration Desk Open
Location: Waller Ballroom Foyer
12:00 PM – 1:00 PM
ASKP3 Expert Faculty Lunch (Invitation Only)
Location: Waller Salon C
1:00 PM – 5:30 PM
ASKP3 Expert Faculty: Mapping the Future (Invitation Only)
Location: Waller Salon A
1:00 PM – 5:30 PM
ASKP3 Expert Faculty: Mapping the Future (Invitation Only)
Location: Waller Salon B
1:00 PM – 5:30 PM
ASKP3 Expert Faculty: Mapping the Future (Invitation Only)
Location: Waller Salon D
5:00 PM – 7:30 PM
Exhibit Hall Open
Location: Moontower Hall
6:00 PM – 7:30 PM
Attendee, Expert Faculty, and Exhibitor Welcome Reception (Poster Presentations)
Location: Moontower Hall
6:00 PM – 7:30 PM
Poster Presentation: A Retrospective Analysis of Ketamine Intravenous Therapy for PTSD in Real-World Care Settings
Location: Moontower Hall
Speaker: Alison McInnes
6:00 PM – 7:30 PM
Poster Presentation: Baseline Monocyte Count Predicts Symptom Improvement During Intravenous Ketamine Therapy in Treatment-Resistant Depression
Location: Moontower Hall
Speaker: Tiago Gil, MD
6:00 PM – 7:30 PM
Poster Presentation: Factors Influencing Response to Ketamine Treatment for Depressive Disorders
Location: Moontower Hall
Speaker: Bikash Sharma, MD
6:00 PM – 7:30 PM
Poster Presentation: Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Location: Moontower Hall
Speaker: Julia Engelhardt, BA
6:00 PM – 7:30 PM
Poster Presentation: Ketamine as a Care Tool in a Brazilian Public Institution: Perspectives of a Social Health Program
Location: Moontower Hall
Speaker: Waledya Araujo Lopes de Melo, MD, MSc. Raquel Pinheiro, MD, Elieser Emidio, MD, Emanuella Sobreira Lacerta Feitosa
6:00 PM – 7:30 PM
Poster Presentation: Once-a-Week IV Ketamine for Treatment-Resistant Depression: A Retrospective Analysis
Location: Moontower Hall
Speakers: Amna Aslam, MBA, MSc., Lauren Bamber, Owen Muir, MD, Irfan Handoo, MD
6:00 PM – 7:30 PM
Poster Presentation: Post-Treatment Lyme Disease Syndrome (PTLDS) Treated With Ketamine and NAD+
Location: Moontower Hall Speaker: Gina Ressler, MD, Rachel Kleckner
6:00 PM – 7:30 PM
Poster Presentation: Stable to Psychedelic: Ketamine and Equine Therapy
Location: Moontower Hall
Speakers: Sara Herman, MD, ABOIM, Alison Hunter, LMFT
7:00 AM – 6:00 PM
Registration Desk Open
Location: Waller Ballroom Foyer
7:00 AM – 6:00 PM
Exhibit Hall Open
Location: Moontower Hall
7:00 AM – 8:00 AM
Attendee and Exhibitor Breakfast
Location: Moontower Hall
8:00 AM – 8:15 AM
Welcome and Opening Remarks
Location: Waller Salons A-D Speaker: Sandhya Prashad, MD
8:15 AM – 8:55 AM
Navigating Responsibility, Standards, and Scrutiny in a Critical Era
Speaker: Rupert McShane, MD, PhD
Location: Waller Salons A-D
8:30 AM – 9:00 AM
Building Community & Shaping the Future of Ketamine Assisted Psychotherapy Together: Updates from the ASKP3 Therapist Advisory Panel
Location: Waller Salons A-D
Speakers: Laura Wiginton, Brittany O’Brien
8:55 AM – 9:40 AM
Undissociating With Ketamine-Assisted Psychotherapy
Location: Waller Salons A-D
Speaker: Chantelle Thomas, PhD
9:40 AM – 10:25 AM
Antisuicidal Effects Ketamine: A Review of the Evidence and Future Directions
Location: Waller Salons A-D
Speaker: Brittany O’Brien, PhD
10:25 AM – 10:55 AM
Refreshment and Networking Break With Exhibitors
Location: Moontower Hall
10:55 AM – 11:40 AM
How (Not What) to Prescribe: Integrating Drug and Non-Drug Aspects of Dissociative Therapies
Location: Waller Salons A-D
Speaker: David Mathai, MD
11:40 AM – 12:25 PM
Modified Couples Ketamine Therapy for Primary and Secondary Post-Traumatic Stress Disorder
Location: Waller Salons A-D
Speaker: Bruce Nadro, DO
12:30 PM – 1:30 PM
Attendee and Exhibitor Lunch
Location: Moontower Hall
1:30 PM – 2:15 PM
Foundation of Care: Outcomes From 2000 Patients, 4 IV Infusions, With an Escalating Dose Protocol
Location: Waller Salons A-D
Speaker: Nicolas Grundmann, MD, MBA
2:15 PM – 3:00 PM
Panel: Insights From the FDA on Safety
Location: Waller Salons A-D
Speakers: Samuel Wilkinson, MD, Brittany O’Brien, PhD, Sandhya Prashad, MD
3:00 PM – 3:45 PM
Stellate Ganglion Block (SGB) as an Adjunct to Ketamine Therapy
Location: Waller Salons A-D
Speakers: Sam Ko, MD, MBA, FACEP, FAAEM,Sara Herman, MD, ABOIM
3:45 PM – 4:15 PM
Refreshment and Networking Break With Exhibitors
Location: Moontower Hall
4:15 PM – 5:05 PM
Enabling Access to Employer-Funded KAT Benefit Coverage
Location: Waller Salon E
Speaker: Marcus Capone, Richard Nockowitz, MD
4:15 PM – 5:05 PM
Esketamine
Location: Waller Salon F
Speakers: Erin Amato, MD, Sandhya Prashad, MD
4:15 PM – 5:05 PM
Ketamine-Assisted EMDR Therapy
Location: 403 – 404
Speaker: Hector Zavala
4:15 PM – 5:05 PM
Neuromodulation With Ketamine for Chronic Pain Utilizing Multidisciplinary Approach: A Case Series
Location: 405
Speaker: Michelle Weiner, MD, Jessica Howarth, DPT, Jenelle Becerra
5:10 PM – 6:00 PM
Capturing the Symbol: Leveraging Deep Self Communication in KAP
Location: 405
Speaker: Jeffrey Becker, MD
5:10 PM – 6:00 PM
Payor Reimbursement – Documentation, Coding, and Billing and Audit Trend
Location: Waller Salon E
Speaker: Christine Pilarski, RHIT, CPC, CPMA, CASCC, CCC AAPC, Harriett Wall, CHC
5:10 PM – 6:00 PM
PEACE Process: A Comprehensive Method for Optimizing Outcomes From Ketamine- Assisted Psychotherapy
Location: 403 – 404
Speaker: Raj Loungani, MD, MPH, FAPA20
7:00 AM – 5:00 PM
Registration Desk Open
Location: Waller Ballroom Foyer
7:00 AM – 5:00 PM
Exhibit Hall Open
Location: Moontower Hall
7:00 AM – 8:00 AM
Attendee and Exhibitor Breakfast
Location: Moontower Hall
8:00 AM – 8:30 AM
Moving the Needle on Insurance Coverage for Ketamine for Mental Health and Chronic Pain
Location: Waller Salons A-D
Speaker: Kimberly Juroviesky, Nurse Practitioner, CAPT, USAF, RET/Disabled, Carlene MacMillan, M.D.
9:00 AM – 9:45 AM
Sub-Dissociative Dose Ketamine: Nine Novel Applications
Location: Waller Salons A-D
Speaker: Lucinda Grande, MD, Sonia Palmieri, ANP-BC, Amy de la Garza, MD, FASAM, IFMCP
9:45 AM – 10:10 AM
Refreshment and Networking Break With Exhibitors
Location: Moontower Hall
10:15 AM – 11:00 AM
Complex Patients – When Ketamine Doesn’t Work
Location: Waller Salon F
Speakers: Erin Amato, MD, Sandhya Prashad, MD
10:15 AM – 11:00 AM
Empowering Transformation: The Role of Ketamine in Facilitating Change and Provider Responsibility
Location: 405
Speaker: Katy Redfield, ARNP
10:15 AM – 11:00 AM
How to Grow Your Clinic With 100% Organic Marketing
Location: Waller Salon E
Speakers: Kimberly Chan Ko, MD, Sam Ko, MD, MBA, FACEP, FAAEM
10:15 AM – 11:00 AM
Ketamine-Assisted Psychotherapy – How Does it Work? Theories of Psychological Mechanisms of Change
Location: 403 – 404
Speaker: Irina Alexander, LMFT, Vilmarie Fraguada Narloch, PsyD
11:05 AM – 11:50 AM
Beyond Surviving: Resolving Sexual Trauma With Ketamine-Assisted Relationship Therapy
Location: 403 – 404
Speaker: Lisa Gold, PhD., LMFT, LPC, CMCH, Wendy Johnson, PMHNP-BC
11:05 AM – 11:50 AM
Efficacy of Addition of IV Glutathione to Standard Ketamine IV Therapy in Major Depressive Disorder
Location: Waller Salon F
Speaker: Ladan Eshkevari, PhD, CRNA
11:05 AM – 11:50 AM
TMS + Ketamine
Location: Waller Salon E
Speakers: Patrick Sullivan, DO, Sandhya Prashad, MD
11:05 AM – 11:50 AM
Innovative Solutions: Intravenous Ketamine’s Role in Chronic Pain Management and Other Potential Applications
Location: 405
Speaker: Charles Miller, MSNA, CRNA
12:00 PM – 12:45 PM
Ketamine & Esketamine for Bipolar Disorder
Location: Waller Salons A-D
Speaker: Brittany O’Brien, PhD, Samuel Wilkinson, MD
12:45 PM – 1:45 PM
Attendee and Exhibitor Lunch
Location: Moontower Hall
1:45 PM – 2:40 PM
Ketamine Clinics: Legal Update
Location: Waller Salons A-D
Speakers: Daniel Sternthal, JD
Attorney at Munsch Hardt Kopf Harr
2:40 PM – 3:10 PM
Ketamine and Neurotoxicity
Location: Waller Salons A-D
Speaker: Samuel Wilkinson, MD
3:10 PM – 4:00 PM
ASKP3 Expert Faculty Update
Location: Waller Salons A-D
4:00 PM – 4:30 PM
Refreshment and Networking Break With Exhibitors
Location: Moontower Hall
4:30 PM – 5:15 PM
Misuse Potential of Ketamine and Relationship With Other Substance Use: Real-World
Evidence
Location: Waller Salons A-D
Speaker: Shahar Almog, PhD
5:15 PM – 6:00 PM
Panel: Areas of Controversy – A Deep Dive Discussion of ASKP3 Public Statements on Home
Use and Treatment in the Setting of Comorbid Substance Use
Location: Waller Salons A-D
Speakers: Jeffrey Becker, MD, Patrick Sullivan, DO, Erin Amato, MD, Sandhya Prashad, MD
6:00 PM – 6:10 PM
Closing Remarks
Location: Waller Salons A-D
Hotel Accommodations
ASKP3 has secured discounted room rates at the Austin Marriott Downtown in Austin, Texas, USA. The discounted room rate is $279/night plus applicable taxes. Ask for the “ASKP” rate when booking your room.
Book your sleeping room accommodations by December 30, 2024 to take advantage of the discounted room rate. Discounted rate available until rooms sell out.
Austin Marriott Downtown
304 East Cesar Chavez Street
Austin, TX 78701
Click here for online booking.
Please note: ASKP3 does not partner with any third-party hotel vendors. Please book directly with the Austin Marriott Downtown.
Faculty
Irina Alexander, LMFT
Alchemy Community Therapy Center
Shahar Almog, PhD
University of Florida
Erin Amato, MD
Montana Psychiatry & Brain Health Center
Lauren Bamber
Jeffrey Becker, MD
Jeff Becker, MD, Inc.
Marcus Capone
TARA Mind
Kimberly Chan Ko, MD
Reset Ketamine
Amy De la Garza, MD, FASAM, IFMCP
Heron Wellness | University of Utah Department of Psychiatry
Ladan Eshkevari, PhD, CRNA
Avesta Mental Health
Tiago Gil
Centro de Cetamina
Lisa Gold
The Arizona Relationship Institute
Lucinda Grande, MD
Pioneer Family Practice
Nicolas Grundmann, MD, MBA
Ember Health
Irfan Handoo, MD
Kansas City Psychiatry Partners
Sara Herman, MD, ABOIM
Soft Reboot Wellness
Jessica Howarth, DPT
NeuroPain Health
Kimberly Juroviesky, Nurse Practitioner, CAPT, USAF, RET/Disabled
Ketamine Taskforce
Sam Ko, MD, MBA, FACEP, FAAEM
Reset Ketamine & Ketamine StartUp
Raj Loungani, MD, MPH, FAPA
Enhance Psych Network
David Mathai, MD
Sattva Medicine/Baylor College of Medicine
Sean McAllister
McAllister Law Office, PC
Alison McInnes
Osmind
Carlene MacMillan, MD
Osmind
Rupert McShane, MD, PhD
University of Oxford
Charles Miller, MSNA, CRNA
Scenic City Neurotherapy
Owen Muir
Bruce Nadro, DO
NM Services, LLC - Mind Relief Foundation
Vilmarie Fraguada Narloch, PsyD
Sana Healing Collective
Richard Nockowitz, MD
TARA Mind
Brittany O'Brien
Baylor College of Medicine
Sonia Palmieri, ANP-BC
Tranquil Healthcare LLC
Christine Pilarski, RHIT, CPC, CPMA, CASCC, CCC AAPC
LW Consulting, Inc.
Sandhya Prashad, MD
Houston Ketamine Therapeutics
Katy Redfield, ARNP
Allay Health And Wellness
Gina Ressler, MD
Advanced Ketamine Services
Daniel Sternthal, JD
Munsch Hardt Kopf Harr
Patrick Sullivan, DO
Initia Nova Medical Solutions, LLC
Chantelle Thomas, PhD
Windrose Recovery
Harriett Wall, CHC
LW Consulting, Inc.
Michelle Weiner
NeuroPain Health
Laura Wiginton, LCSW
Laura Wiginton LCSW
Samuel Wilkinson, MD
Yale University
Hector Zavala
Light of Wellness and Counseling
How to Receive CME Credit
To receive CME credits, ASKP3 has partnered with PeerPoint Medical Education Institute. Attendees will be provided instructions on self-reporting to PeerPoint Medical Education Institute following completion of the program.
To receive CE credits, ASKP3 has partnered with the American Association of Nurse Anesthesiology (AANA). Attendees will be provided with a Program Evaluation and Learner Assessment to complete via email at the closure of the Conference. Attendees that complete and return the Program Evaluation and Learner Assessment will have their participation and CEs reported to the AANA by ASKP3 staff.
Disclaimer
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a licensed professional relative to diagnostic and treatment options of a specific patient’s medical condition.
Statements by industry representatives during the program may not reflect the views and opinions of the ASKP3, its Board of Directors, faculty, or staff